CYP2D6 polymorphisms influence tamoxifen treatment outcomes in

SciELO - Brasil - Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer Impactos do polimorfismo genético do citocromo P450 2D6 (CYP2D6) na terapia com tamoxifeno para

CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis

Medicina, Free Full-Text

Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment - Stefan A. J. Buck, C. Louwrens Braal, Maaike M. Hofman, Esther Oomen-de Hoop, Peter de Bruijn

Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer, Egyptian Journal of Medical Human Genetics

PDF] CYP2D6 polymorphisms and their influence on risperidone treatment

Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis - ScienceDirect

CYP2D6 Genotyping for Personalized Therapy of Tamoxifen in Indonesian Women with ER+ Breast Cancer

Full article: Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment

Frontiers Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites

JPM, Free Full-Text

CYP2D6 does not impact on breast cancer-free survival in Southeast Mexican patients under tamoxifen treatment

PDF] Pharmacogenomics of tamoxifen therapy.

Explore the distribution of (rs35742686, rs3892097 and rs1065852) genetic polymorphisms of cytochrome P4502D6 gene in the Moroccan population, Egyptian Journal of Medical Human Genetics